Assessing the impact and safety of Home IntraVenous Antibiotic Treatment (IVAT) for children with cystic fibrosis
Not Applicable
Completed
- Conditions
- Cystic fibrosis, respiratory diseaseNutritional, Metabolic, EndocrineCystic fibrosis
- Registration Number
- ISRCTN65724841
- Lead Sponsor
- Royal Liverpool Children's NHS Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
1. Children aged 13 years or under
2. Confirmed diagnosis of CF for at least one year
3. Caregiver has opted to conduct the IVAT procedure him or herself at home
4. Target gender: male and female
Exclusion Criteria
1. Caregivers administering end-of-life care
2. Profound mental, physical or social problems involving statutory services
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method